Title:
腫瘍拒絶抗原先駆体MAGE‐3をコード化する分離された核酸分子とその利用
Document Type and Number:
Japanese Patent JP3594307
Kind Code:
B2
Abstract:
The invention relates to nucleic acid molecules which code for the tumor rejection antigen precursor MAGE-6. Also disclosed are vectors, cell lines, and so forth, which utilize the nucleic acid molecule, and optionally, molecules coding for human leukocyte antigen HLA-A1. Use of these materials in therapeutic and diagnostic contexts are also a part of the invention.
Inventors:
Beatler, Beatrice
Van den Einde, Benoit
Boone-Farrer, Thierry
Van der burggen, pierre
Van den Einde, Benoit
Boone-Farrer, Thierry
Van der burggen, pierre
Application Number:
JP52211494A
Publication Date:
November 24, 2004
Filing Date:
March 17, 1994
Export Citation:
Assignee:
LUDWIG INSTITUTE FOR CANCER RESEARCH
International Classes:
A61K31/70; A61K9/127; A61K35/12; A61K35/14; A61K35/18; A61K38/00; A61K39/00; A61K39/39; A61K39/395; A61K48/00; A61P35/00; C07K7/06; C07K14/00; C07K14/47; C07K14/52; C07K14/525; C07K14/54; C07K14/55; C07K14/705; C07K16/00; C07K16/30; C07K16/42; C07K17/00; C12N1/00; C12N1/20; C12N1/21; C12N5/10; C12N7/00; C12N15/00; C12N15/02; C12N15/09; C12N15/12; C12P21/02; C12P21/08; C12Q1/00; C12Q1/68; G01N33/50; G01N33/53; G01N33/574; G01N33/577; G01N33/68; C12R1/19; C12R1/91; (IPC1-7): C12N15/00
Foreign References:
| WO1992020356A1 |
Other References:
Immunogenetics,Vol.35(1992) P.145-152
Attorney, Agent or Firm:
Shuichiro Kitamura